In the past 30 days, 2024 loss estimates for Akebia have improved from 28 cents per share to 19 cents per share. For 2025, loss estimates have improved from 23 cents to 17 cents per share in the ...

The FDA, which turned away Akebia's initial application last March 2022, has a target action of Wednesday on the company's resubmission, which included Explore Our Brands WSJ ...

One basic question that you might not know: Is avocado a fruit or vegetable? Before we answer the question “Is avocado a fruit or vegetable?” it’s important to understand the difference ...

Dried fruit has a reputation for being high in calories and sugar, but experts say it can be just as good for you as fresh. True, dried fruit will have more sugar by weight than the fresh version ...

When Amos Abolaji returned to Nigeria from a year abroad, he brought home a strange souvenir — two jars full of fruit flies. The biochemist had been conducting postdoctoral research at the ...

Oct. 15, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced ...

CAMBRIDGE, Mass., Oct. 1, 2024 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease ...

The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GSK’s Jesduvroq.

October 14, 2024: We have searched and added five Fruit Battlegrounds codes to this list. What are the new Fruit Battlegrounds codes? Codes for this Roblox game are a must-have if you want to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Akebia Therapeutics, Inc. (NASDAQ:AKBA) has announced an extension of its supply agreement with STA Pharmaceutical Hong Kong Limited, as per the recent 8-K filing with the Securities and Exchange ...